Pre-existing Immune Status Associated with Response to Combination of Sipuleucel-T and Ipilimumab in Patients with Metastatic Castration-Resistant Prostate Cancer
Journal for immunotherapy of cancer(2021)
Key words
clinical trials,phase II as topic,immunotherapy,prostatic neoplasms,CTLA-4 antigen,immunogenicity,vaccine
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined